Interacting Drugs |
Nefazodone vs Tolterodine |
Security Level |
|
Mechanism |
Tolterodine: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Tolterodine. |
Management |
The maximum recommended dose of long-acting tolterodine is 2 mg/day when used together with a strong CYP3A4 inhibitor. |
Nefazodone vs Tolterodine
Post Review about Nefazodone vs Tolterodine Click here to cancel reply.
Other Interactions of Nefazodone
Other Interactions of Tolterodine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.